Back
Haemonetics Corp. 10K Form
Buy
68
HAE
Haemonetics Corp.
Last Price:
$83.79
Seasonality Move:
-0.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-08 | 10Q | HAE/Haemonetics Corp. Quarterly |
| 2023-11-02 | 10Q | HAE/Haemonetics Corp. Quarterly |
| 2023-08-08 | 10Q | HAE/Haemonetics Corp. Quarterly |
| 2023-02-07 | 10Q | HAE/Haemonetics Corp. Quarterly |
| 2022-11-08 | 10Q | HAE/Haemonetics Corp. Quarterly |
| 2022-08-10 | 10Q | HAE/Haemonetics Corp. Quarterly |
Receive HAE News And Ratings
See the #1 stock for the next 7 days that we like better than HAE
HAE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.4B |
|---|---|
| Cash Flow: | $106.3M |
| Price / Cash Flow: | 16.05 |
| Annual Sales: | $18.17 |
| Price / Book: | 4.62 |
Profitability
| EPS (TTM): | 3.42770 |
|---|---|
| Net Income (TTM): | $168.2M |
| Gross Margin: | $715.3M |
| Return on Equity: | 19.39% |
| Return on Assets: | 6.78% |
Haemonetics Corp. Earnings Forecast
Key Haemonetics Corp. Financial Ratios
-
The Gross Profit Margin over the past 37 years for HAE is 52.57%.
-
The Selling, General & Administrative Expenses for HAE have been equal to 32.10% of Gross Profit Margin.
-
The Research & Development expenses have been 4.49% of Revenue.
-
The Interest Expense is 5.90% of Operating Income.
-
The Net Earning history of HAE is 12.32% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 22 years.
Haemonetics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | HAE |
| CUSIP: | 405024 |
| Website: | haemonetics.com |
Debt
| Debt-to-Equity Ratio: | 1.44 |
|---|---|
| Current Ratio: | 1.64 |
| Quick Ratio: | 0.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.36 |
|---|---|
| Forward P/E Ratio: | 15.26 |
HAE Technical Analysis vs Fundamental Analysis
Buy
68
Haemonetics Corp. (HAE)
is a Buy
Is Haemonetics Corp. a Buy or a Sell?
-
Haemonetics Corp. stock is rated a BuyThe current Haemonetics Corp. [HAE] share price is $83.81. The Score for HAE is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.